PharmaShots | Incisive News in 3 Shots

Subscribe Now

InDex Pharmaceuticals

InDex Pharmaceuticals Entered into a License Agreement with Viatris to Develop and Commercialize Cobitolimod for Ulcerative Colitis in Japan

InDex Pharmaceuticals Entered into a License Agreement with Viatris to Develop and Commercialize Cobitolimod for Ulcerative Coliti...

June 1, 2023

InDex Pharmaceuticals Reports Positive PK Results from Cobitolimod in Patients with Ulcerative Colitis

InDex Pharmaceuticals Reports Positive PK Results from Cobitolimod in Patients with Ulcerative Colitis

March 15, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us